First Time Loading...
V

Vor Biopharma Inc
NASDAQ:VOR

Watchlist Manager
Vor Biopharma Inc
NASDAQ:VOR
Watchlist
Price: 1.68 USD -1.18%
Updated: May 15, 2024

Vor Biopharma Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vor Biopharma Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
V
Vor Biopharma Inc
NASDAQ:VOR
Interest Income Expense
$8.2m
CAGR 3-Years
548%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Vor Biopharma Inc's Interest Income Expense?
Interest Income Expense
8.2m USD

Based on the financial report for Dec 31, 2023, Vor Biopharma Inc's Interest Income Expense amounts to 8.2m USD.

What is Vor Biopharma Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
548%

Over the last year, the Interest Income Expense growth was 519%. The average annual Interest Income Expense growth rates for Vor Biopharma Inc have been 548% over the past three years .